Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites. Shannon A, Le NT, Selisko B, Eydoux C, et al. Antiviral Res 2020;178:104793.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shannon A, Le NT, Selisko B, Eydoux C, et al. Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites. Antiviral Res 2020;178:104793.
PMID: 32283108